Marie Paule Kieny
Biographic Data
| ID | 6078902 |
|---|---|
| NAME | Marie Paule Kieny |
| GIVEN NAMES | Marie Paule |
| FAMILY NAME | Kieny |
| SIGNATURE | KIENY M P |
| AFFILIATIONS | Medicines Patent Pool |
| ORCID | 0000-0002-5943-6488 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 1 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2004 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 1 |
Negotiating public-health intellectual property licensing agreements to increase access to health technologies
Public health voluntary licensing of intellectual property has successfully been applied to increase access to medicines in certain disease areas, producing health benefits and economic savings, particularly in low-income and middle-income countries. There is however limited understanding of the intricacies of the approach, the modalities by which it works in practice, its levers and the trade-offs made. Such knowledge may be critical in deciding…
Research and Development of New Vaccines Against Infectious Diseases
Infectious diseases are responsible for approximately 25% of global mortality, especially in children aged younger than 5 years. Much of the burden of infectious diseases could be alleviated if appropriate mechanisms could be put in place to ensure access for all children to basic vaccines, regardless of geographical location or economic status. In addition, new safe and effective vaccines should be developed for a variety of infections against w…
Research and Development of New Vaccines Against Infectious Diseases
Infectious diseases are responsible for approximately 25% of global mortality, especially in children aged younger than 5 years. Much of the burden of infectious diseases could be alleviated if appropriate mechanisms could be put in place to ensure access for all children to basic vaccines, regardless of geographical location or economic status. In addition, new safe and effective vaccines should be developed for a variety of infections against w…
Research and Development of New Vaccines Against Infectious Diseases
Infectious diseases are responsible for approximately 25% of global mortality, especially in children aged younger than 5 years. Much of the burden of infectious diseases could be alleviated if appropriate mechanisms could be put in place to ensure access for all children to basic vaccines, regardless of geographical location or economic status. In addition, new safe and effective vaccines should be developed for a variety of infections against w…
Negotiating public-health intellectual property licensing agreements to increase access to health technologies
Public health voluntary licensing of intellectual property has successfully been applied to increase access to medicines in certain disease areas, producing health benefits and economic savings, particularly in low-income and middle-income countries. There is however limited understanding of the intricacies of the approach, the modalities by which it works in practice, its levers and the trade-offs made. Such knowledge may be critical in deciding…
Economics (2 works) · Medicine (2 works) · Public health (2 works) · Biotechnology and Related Fields (1 work) · Business (1 work) · Economic growth (1 work) · Environmental health (1 work) · Health Systems, Economic Evaluations, Quality of Life (1 work) · Immunology (1 work) · Immunology (1 work)